Cell Expansion Market Research Report Information By Product (Consumables [Reagents, Media, & Serum, Other Consumables], Culture Flasks and Accessories [Tissue Culture Flasks, Other Culture Flasks and Accessories], Instruments [Automated Cell Expansion Systems, Bioreactors, Other Instruments]), By Cell Type (Mammalian [Human], Animal, Others), By Application (Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research And Others), By End-Use (Biopharmaceutical & B

Global Cell Expansion Market Overview

Cell Expansion Market Size was valued at USD 14.8 Billion in 2023. The Cell Expansion Market industry is projected to grow from USD 16.7 Billion in 2024 to USD 39.3 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 13.00% during the forecast period (2024 - 2032). Growing financing and investment in regenerative medicine, as well as increasing demand for cell expansion technology, are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Cell Expansion Market Trends

• Increasing Prevalence of Chronic Diseases Propels Market Growth

The increasing prevalence of chronic diseases is a major factor driving the market CAGR in Cell Expansion. Cell expansion is used to develop new medications for treating ailments and to manufacture vaccines, medicines, treatments, and antibiotics. Because of the increasing prevalence of diseases such as cancer and diabetes, there is an urgent need for in-depth study to develop novel treatment alternatives. According to the International Diabetes Federation (IDF), the number of people living with diabetes is anticipated to rise from 425 million in 2017 to 629 million by 2045. Cancer was the leading cause of mortality in 2018, accounting for 9.6 million deaths worldwide. According to GLOBOCAN, there will be more than 30 million new cancer cases by 2040, up from 18 million in 2018. Cell expansion is a critical component of this research since the prevalence of many disorders is increasing, necessitating large-scale investigations for diagnosis and treatment.

Most emerging markets are expected to have growth in the cell expansion market. In recent years, countries such as India, Brazil, and China have seen considerable growth in their biotechnology and pharmaceutical industries. This pattern is expected to prevail for the forecasted period. The India Brand Equity Foundation predicts that the biotechnology business in India will grow from USD 11 billion in 2016 to USD 100 billion by 2025 at a rate of 30.46 percent (IBEF). The same source forecasts a USD 55 billion pharmaceutical market in India by 2020, up from USD 36.7 billion in 2016. Brazil's pharmaceutical market is expected to increase from USD 25.3 billion in 2016 to USD 29.9 billion by 2021. As these countries' biotechnology and pharmaceutical sectors grow, there will be a greater demand for cell expansion products for research and development and pharmaceutical product manufacturing.

Moreover, increased government investment in research and development is likely to drive future growth in the cell expansion market. Government financing is money granted by the government to pay for a certain purpose. Increasing government financing for cell expansion research and development is critical to stimulating innovation, pushing advances in cell-based therapeutics, and advancing regenerative medicine progress. For example, in September 2023, the National Cancer Institute, a US-based government organization, obtained a $7.3 billion budget from Congress for fiscal year 2023, representing a $408 million increase over fiscal year 2022. Thus driving the Cell Expansion Market revenue.

Cell Expansion Market Segment Insights

Cell Expansion Product Insights

The Cell Expansion Market segmentation, based on Product, includes Consumables [Reagents, Media, & Serum, Other Consumables], Culture Flasks and Accessories [Tissue Culture Flasks, Other Culture Flasks and Accessories], Instruments [Automated Cell Expansion Systems, Bioreactors, Other Instruments]. Consumables led the product segment in 2023, accounting for the greatest sales share. It is predicted to maintain its excellent position over the forecast years. This category's significant revenue share is due to the availability of a diverse range of commercial media and reagents customized to certain types of cells. These products are also widely available and ready to use and come in serum-free compositions.

Cell Expansion Cell Type Insights

The Cell Expansion Market segmentation, based on Cell Type, includes Mammalian [Human], Animal, and Others. The mammalian cells segment, which had the highest revenue share in 2023, will remain dominant throughout the projection period. This is because post-translational alterations in humans affect these systems in both pharmacological and functional ways. As a result, these culture methods are used to make the great majority of biopharmaceuticals, such as monoclonal antibodies, interferons, thrombolytics, and therapeutic enzymes.

Figure 1: Cell Expansion Market, by Cell Type, 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Cell Expansion Application Insights

The Cell Expansion Market segmentation, based on Application, includes biopharmaceuticals, tissue culture & engineering, vaccine production, drug development, gene therapy, cancer research, stem cell research and others. The biopharmaceuticals had the highest revenue share in 2023, owing to an increase in the number of biopharmaceutical drugs approved in recent years. The introduction of new biopharmaceutical enterprises and the dissemination of bioprocessing technologies bolster biopharmaceutical development, which in turn supports the expansion of bioproduction methods. Furthermore, single-use technologies are rapidly taking over the commercial production of cellular therapies.

Cell Expansion End-Use Insights

The Cell Expansion Market segmentation, based on End-Use, includes biopharmaceutical & biotechnology companies, research institutes, cell banks, and others. The market for biopharmaceutical & biotechnology companies had the largest share in 2023 and is expected to increase significantly further. One of the key reasons for the high number of biopharmaceutical companies is the growing potential of cell-based medicines in the healthcare business. Cellular-based therapies, for example, have grown in popularity in regenerative medicine as a result of ongoing advances in injectable cell delivery systems for a wide range of therapeutic applications.

Cell Expansion Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and the Rest of the World. North America had the largest percentage in 2023, owing to increasing government financing initiatives that have boosted stem cell production and the development of regenerative medicine and cellular therapy products; the area is expected to maintain its lead in future years. This increases the demand for cell expansion platforms in this region. For instance, in October 2019, the FDA and the Medical Technologies Enterprise Consortium (MTEC) awarded USD 5.3 million to the Southwest Research Institute (SwRI). (U.S.). The SwRI used this money to distribute cells to advance customized regenerative medicine.

Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2: CELL EXPANSION MARKET SHARE BY REGION 2023 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe Cell Expansion Market accounts for the second-largest market share. This is due to increased research methods in the realm of advanced therapies such as tissue engineering and regenerative medicine, significant government investments and funding for R&D, and expanding biotechnology enterprises. Further, the German Cell Expansion Market held the largest market share, and the UK Cell Expansion Market was the fastest-growing market in the European region.

The Asia-Pacific Cell Expansion Market is expected to grow at the fastest CAGR from 2024 to 2032. This is due to the increased efforts of various local pharmaceutical and biotechnology businesses to develop and commercialize their cellular therapies. Moreover, China’s Cell Expansion Market held the largest market share, and the Indian Cell Expansion Market was the fastest-growing market in the Asia-Pacific region.

Cell Expansion Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Cell Expansion Market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Cell Expansion industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Cell Expansion industry to benefit clients and increase the market sector. In recent years, the Cell Expansion industry has offered some of the most significant advantages to medicine. Major players in the Cell Expansion Market, including Thermo Fisher Scientific, Inc., GE Healthcare, Corning, Inc., STEMCELL Technologies, Inc., Merck KGaA, Miltenyi Biotec and others, are attempting to increase market demand by investing in research and development operations.

StemCell Technologies Canada Inc. is a Canadian biotechnology firm that creates and produces cell culture media and cell separation technologies for use in stem cell, immunology, and cancer research. In April 2022, STEMCELL Technologies Canada and Applied Cells Inc. collaborated to develop a new method of cell separation by combining Applied Cells' MARS platform with STEMCELL's EasySep kits, making isolating cells from varied samples easier and more automatic. These samples can come from whole blood, bone marrow, apheresis products, or tissue. The collaboration's goal is to improve the efficiency and effectiveness of cell separation for research and medical applications.

Danaher Corporation is an American multinational conglomerate created in 1984 by brothers Steven and Mitchell Rales. The company is headquartered in Washington, D.C. and creates, manufactures, and markets medical, industrial, and commercial products and services. It has expanded mostly through acquisitions and has traditionally strived to keep a low public presence. Danaher was one of the first firms in North America to implement the Kaizen principles to manufacturing, which is a lean manufacturing Japanese philosophy of continual improvement and waste elimination. In March 2020, Danaher Corp. successfully acquired General Electric Co.'s biopharma division for USD 21.4 billion. The business, Cytiva, will operate independently within Danaher's biosciences division.

Key Companies in the Cell Expansion Market include

• Thermo Fisher Scientific, Inc.


• GE Healthcare


• Corning, Inc.


• STEMCELL Technologies, Inc.


• Merck KGaA


• Miltenyi Biotec


• Becton, Dickinson and Company


• Terumo Bct, Inc.


• Sartorius AG


• Takara Bio, Inc.

Cell Expansion Industry Developments

In December 2023, FUJIFILM Corporation, a multinational conglomerate, invested USD 200 million in two subsidiaries to significantly improve its global cell therapy contract development and manufacture (CDMO) capabilities. The investment will enable Fujifilm to support its expanding cell therapy business, which is forecast to grow by more than 30% annually from USD 3.3 billion in FY2022.

In February 2023, Terumo Blood and Cell Technologies, a medical technology company, presented data from their Quantum Flex Cell Expansion System for the first time at a major conference, demonstrating how its hollow-fiber perfusion technique accelerates T-cell therapy development in a variety of bioreactors. Terumo BCT scientists presented the findings of numerous T-cell growth experiments at the CAR-TCR Summit Europe in London, revealing a 60% to 70% reduction in medium utilization and 8.7 to 9.6 population doublings over 8 days.

Cell Expansion Market Segmentation

Cell Expansion Product Outlook

• Consumables


• Reagents, Media & Serum


• Other Consumables


• Culture Flasks and Accessories


• Tissue Culture Flasks


• Other Culture Flasks and Accessories


• Instruments


• Automated Cell Expansion Systems


• Bioreactors


• Other Instruments

 Cell Expansion Cell Type Outlook

• Mammalian


• Human


• Animal


• Others

Cell Expansion Application Outlook

• Biopharmaceuticals


• Tissue Culture & Engineering


• Vaccine Production


• Drug Development


• Gene Therapy


• Cancer Research


• Stem Cell Research


• Others

Cell Expansion End-User Outlook

• Biopharmaceutical & Biotechnology Companies


• Research Institutes


• Cell Banks


• Others

Cell Expansion Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America